Trevena, Inc. (TRVN) CEO To Present At The Barclays Global Healthcare Conference
3/5/2014 9:07:05 AM
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company and leader in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Maxine Gowen, Ph.D., its president and chief executive officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 11, 2014 at 10:45 a.m. ET in Miami, FL.
Help employers find you! Check out all the jobs and post your resume.
comments powered by